Survival of patients with Duchenne muscular dystrophy
- PMID: 30571821
- DOI: 10.4067/S0370-41062018005000704
Survival of patients with Duchenne muscular dystrophy
Abstract
Introduction: Duchenne muscular dystrophy (DMD) leads to a progressive deterioration of the mus cle function and premature death. There are no longitudinal studies on the course of this pathology in Chile.
Objective: To determine survival between the years 1993-2013, divided into two periods (1993-2002 and 2003-2013), and the effect of social determinants in patients with DMD admitted in Teleton Institutes of Chile (TI).
Patients and method: Prospective follow-up study in a clinical series of 462 patients with DMD. The information was obtained by searching for patients with DMD in OLAP cube (Online Analytical Processing). From the clinical records of the TI of Santiago, the variables corresponding to the diagnostic method, stage of DMD described in terms of muscle de terioration and function according to Swinyard classification were recorded; existence and type of tests that conclude the diagnosis and, in the cases reported, the existence of family history. Kaplan Meier survival analysis was applied, where global survival was defined between birth and age of death. The determinant factors analyzed were estimated through the Cox-Snell's proportional risk model.
Results: Survival at 20 years of age from TI entry was 51.7% (CI95%: 45.1-57.8), 48.5% in the period 1993-2002 and 72.8% between 2003-2013. The percentage of survival at the same age according to socioeconomic status (SES) was 82% in high SES, 67% in middle SES, and 42% in low SES, with a statistically significant difference between high and middle SES in relation to extreme poverty. Ac cording to country areas, the survival was close to 75 % at 17 years of age.
Conclusions: The survival information from patients with DMD from childhood to adult life is valuable for predicting the clinical course of the disease with the current medical care. There is evidence of improvement in the probability of survival at the age of 20 and marked inequity according to the socioeconomic variable.
Similar articles
-
Disability and survival in Duchenne muscular dystrophy.J Neurol Neurosurg Psychiatry. 2009 Mar;80(3):320-5. doi: 10.1136/jnnp.2007.141721. Epub 2008 Aug 19. J Neurol Neurosurg Psychiatry. 2009. PMID: 18713792
-
Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients.Acta Myol. 2012 Oct;31(2):121-5. Acta Myol. 2012. PMID: 23097603 Free PMC article.
-
Survival among patients receiving eteplirsen for up to 8 years for the treatment of Duchenne muscular dystrophy and contextualization with natural history controls.Muscle Nerve. 2024 Jul;70(1):60-70. doi: 10.1002/mus.28075. Epub 2024 Mar 14. Muscle Nerve. 2024. PMID: 38482981
-
Life Expectancy in Duchenne Muscular Dystrophy: Reproduced Individual Patient Data Meta-analysis.Neurology. 2021 Dec 7;97(23):e2304-e2314. doi: 10.1212/WNL.0000000000012910. Epub 2021 Oct 13. Neurology. 2021. PMID: 34645707 Free PMC article.
-
Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.JAMA Neurol. 2016 Jan;73(1):111-6. doi: 10.1001/jamaneurol.2015.3537. JAMA Neurol. 2016. PMID: 26594870 Review.
Cited by
-
Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis.Eur J Epidemiol. 2020 Jul;35(7):643-653. doi: 10.1007/s10654-020-00613-8. Epub 2020 Feb 27. Eur J Epidemiol. 2020. PMID: 32107739 Free PMC article.
-
Females with X-Linked Muscle Disorders: an underestimated patient population.Acta Myol. 2025 Mar;44(1):33-36. doi: 10.36185/2532-1900-1096. Acta Myol. 2025. PMID: 40183439 Free PMC article. Review.
-
Survival in Duchenne muscular dystrophy in Australia: a 50 year retrospective cohort study.Lancet Reg Health West Pac. 2025 May 8;58:101568. doi: 10.1016/j.lanwpc.2025.101568. eCollection 2025 May. Lancet Reg Health West Pac. 2025. PMID: 40470523 Free PMC article.
-
Natural history of Duchenne muscular dystrophy in the United Kingdom: A descriptive study using the Clinical Practice Research Datalink.Brain Behav. 2023 Dec;13(12):e3331. doi: 10.1002/brb3.3331. Epub 2023 Nov 13. Brain Behav. 2023. PMID: 37957895 Free PMC article.
-
Selected clinical and demographic factors and all-cause mortality among individuals with Duchenne muscular dystrophy in the Muscular Dystrophy Surveillance, Tracking, and Research Network.Neuromuscul Disord. 2022 Jun;32(6):468-476. doi: 10.1016/j.nmd.2022.04.008. Epub 2022 Apr 30. Neuromuscul Disord. 2022. PMID: 35597713 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources